Skip to main content
Clinical Trials/CTRI/2023/06/053653
CTRI/2023/06/053653
Not yet recruiting
未知

Evaluation of periodontal inflamed surface area, serum Interleukin-12, Interleukin-18 levels in Stage III periodontitis patients with and without Type 2 Diabetes Mellitus- A Cross Sectional Study

none0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
none
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • Group I Periodontally healthy patients GI is equal to0 probing depth PPD less than or equal to 3 mm CAL is equal to 0 with no radiographic evidence of bone loss
  • Group II Stage III periodontitis with GI greater than 1 PPD more than or equal to 6mm and CAL more than or equal to 5mm
  • Group III Stage III periodontitis with T2DM patients GI more than 1 PPD more than or equal to 6mm and CAL more than or equal to 5mm HbA1c levels between 5 to 7 percent

Exclusion Criteria

  • Patients who have undergone any periodontal therapy in the past 6 months
  • Patients with symptoms of acute illness
  • Patients who are on immunosuppressive therapy
  • Systemic anti inflammatory treatment within the previous 3 months or regular use of specific drugs known to affect periodontal tissues
  • Pregnant women and lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials